PuroMill Resins featured in Pharma Intelligence CPhI North America Preview Edition

Purolite's novel polymeric milling media was featured in the Pharma intelligence CPhi North America Preview published by Informa.

The article describes the physical characteristics of the media that makes it perform better than traditional media (such as YTZ) for creating nanoparticles in wet milling drug formulation processes.

Purolite, a wear-resistent bead-form polymeric media has a Drug Master File register with the U.S. FDA and is manufactured in an FDA inspected, cGMP certified facility.

The media enables the creation of pure drug nanoparticles <100 nm, which can enhance drug solubility for compounds with poor aqueous solubility.

PuroMill polymeric milling media can be used for small-molecule compounds for oral, parental, ocular, inhalable and other dosage forms to help improve solubility.